tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
Holding RAPP?
Track your performance easily

Rapport Therapeutics, Inc. (RAPP) Income Statement

18 Followers

Rapport Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Rapport Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q3, Rapport Therapeutics, Inc.'s net income was $-17.54M. See Rapport Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 36.18M
Operating Income
$ -36.18M
Net Non Operating Interest Income Expense
$ 2.53M
Other Income Expense
$ 1.12M
Pretax Income
$ -34.78M
Tax Provision
$ 10.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -34.79M
Basic EPS
$ -23.10
Diluted EPS
$ -23.10
Basic Average Shares
$ 1.51M
Diluted Average Shares
$ 1.51M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 36.18M
Net Income From Continuing And Discontinued Operation
$ -34.79M
Normalized Income
$ -25.56M
Interest Expense
-
EBIT
$ -34.78M
EBITDA
$ -34.66M
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis